Cargando…
A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated by Hepatic Arterial Infusion Chemotherapy and Radiotherapy
Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Additionally, hepatic arterial infusion chemotherapy has been used as a treatment option for advanced HCC. Here, we report a case of sustained partial response in a patient with advance...
Autores principales: | Lee, Jin Yong, Yoo, Jeong-Ju, Chun, Seong Joon, Bae, Sun Hyun, Lee, Jae Myeong, Kim, Sang Gyune, Kim, Young Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Liver Cancer Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035700/ https://www.ncbi.nlm.nih.gov/pubmed/37383060 http://dx.doi.org/10.17998/jlc.20.1.78 |
Ejemplares similares
-
Early Experience of Oncolytic Virus Injection Combined with Sorafenib in a Patient with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis
por: Jo, Hyun Ho, et al.
Publicado: (2020) -
Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Ahn, Young Eun, et al.
Publicado: (2021) -
INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
por: Song, Xiaodong, et al.
Publicado: (2020) -
The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
por: Bae, Bong Kyung, et al.
Publicado: (2016) -
Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply
por: Yim, Hyung Joon, et al.
Publicado: (2023)